Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737.

MLA

Oakes, Samantha R., et al. “Sensitization of BCL-2-Expressing Breast Tumors to Chemotherapy by the BH3 Mimetic ABT-737.” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 8, Feb. 2012, pp. 2766–71. EBSCOhost, https://doi.org/10.1073/pnas.1104778108.

APA

Oakes, S. R., Vaillant, F., Lim, E., Lee, L., Breslin, K., Feleppa, F., Deb, S., Ritchie, M. E., Takano, E., Ward, T., Fox, S. B., Generali, D., Smyth, G. K., Strasser, A., Huang, D. C. S., Visvader, J. E., & Lindeman, G. J. (2012). Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737. Proceedings of the National Academy of Sciences of the United States of America, 109(8), 2766–2771. https://doi.org/10.1073/pnas.1104778108

Chicago

Oakes, Samantha R, François Vaillant, Elgene Lim, Lily Lee, Kelsey Breslin, Frank Feleppa, Siddhartha Deb, et al. 2012. “Sensitization of BCL-2-Expressing Breast Tumors to Chemotherapy by the BH3 Mimetic ABT-737.” Proceedings of the National Academy of Sciences of the United States of America 109 (8): 2766–71. doi:10.1073/pnas.1104778108.